Kinsale Capital Group, Inc. (KNSL) Stock Price & Analysis
Kinsale Capital Group, Inc. (KNSL) rose 0.00% to USD 349.1 as of July 25, 2026 at 02:25 UTC, according to Nexqual real-time market data.
KNSL last closed at USD 349.1; the session ranged USD 334.91–356.25 on volume of 575,135 shares. Market capitalization is —, with a 52-week range of USD 287.2–512.76 (NYQ). Source: Nexqual, July 25, 2026 at 02:25 UTC.
Key Statistics (as of July 25, 2026 at 02:25 UTC)
| Price | USD 349.1 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 349.1 |
| Open | USD 349.1 |
| Day Range | USD 334.91 – 356.25 |
| 52-Week Range | USD 287.2 – 512.76 |
| Volume | 575,135 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (KNSL)
Nexqual's technical model rates KNSL "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 02:25 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.85 (neutral) |
| vs SMA50 | Above (USD 319.96) |
| MACD | 5.16 (positive) |
From Kinsale Capital Group, Inc.'s Latest SEC 10-K Filing (filed 2026-02-20)
Key Strengths & Strategy (as disclosed to the SEC)
- Using our proprietary technology platform and leveraging the expertise of our highly-experienced employees in our daily operations, we have built a company that is entrepreneurial and highly efficient.
- We believe that the combination of our proprietary technology platform and our expense management allows us to process quotes, underwrite policies and operate with a substantial cost advantage over our direct competitors.
- We use our proprietary technology platform to drive a high level of efficiency, accuracy and speed in our underwriting and quoting process.
- We have built a proprietary technology platform that reflects the best practices our management team has learned from its extensive experience.
Partnerships
- Our investment policy is designed to comply with the regulatory investment requirements and restrictions to which our insurance subsidiary is subject.
- Trade Representative announced their intention to exercise their authority under the Dodd-Frank Act to negotiate a "covered agreement" with the European Union (the "Covered Agreement").
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WD | Walker & Dunlop, Inc | USD 48.2 | ▲ 0.98% |
| LOB | Live Oak Bancshares, Inc. | USD 42.08 | ▲ 2.51% |
| MEDP | Medpace Holdings, Inc. | USD 601.38 | ▲ 13.87% |
| FLGT | Fulgent Genetics, Inc. | USD 19.67 | ▲ 0.72% |
| APPN | Appian Corporation | USD 23.75 | ▲ 4.9% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:25 UTC. This page is informational and not investment advice.